CANCERNET
DEAD

Serial Number

87070319

Owner

Cellecta, Inc.

First Use Date

Feb 25, 2016

Filing Date

Jun 14, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CANCERNET Trademark

Serial Number: 87070319

CANCERNET is a trademark filed by Cellecta, Inc. on June 14, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Cellecta, Inc. (4 trademarks)

320 Logue Avenue
Mountain View, CA 94043

Entity Type: 03

Trademark Details

Filing Date

June 14, 2016

Registration Date

Not Registered

First Use Anywhere

February 25, 2016

First Use in Commerce

February 25, 2016

Goods & Services

Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Reagents for medical use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sepsis; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Reagents and media for medical and veterinary diagnostic purposes

Assays for research purposes; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific use; Diagnostic reagents for scientific or research use; Reagents for research purposes; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology

Health care services, namely, providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Medical diagnostic testing, monitoring and reporting services; Medical screening services in the field of cancer; Medical testing for diagnostic or treatment purposes; Genetic testing of animals for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Biological research; Biomedical research services; DNA analysis services for scientific research purposes; Laboratory research services relating to pharmaceuticals; Laboratory research in the field of genetics; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Research and development of new products; Research on the subject of pharmaceuticals; Scientific laboratory services; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Research and development and consultation related thereto in the field of genetics; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of genetics; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 12, 2017 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 12, 2017 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2016 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2016 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2016 CNRT
ASSIGNED TO EXAMINER
Sep 14, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 20, 2016 NWOS
NEW APPLICATION ENTERED
Jun 17, 2016 NWAP